Anjan Debnath, Claudia M Calvet, Gareth Jennings, Wenxu Zhou, Alexander Aksenov, Madeline R Luth, . . . Larissa M Podust. (2017). CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationAnjan Debnath, et al. CYP51 Is an Essential Drug Target for the Treatment of Primary Amoebic Meningoencephalitis (PAM). Public Library of Science (PLoS), 2017.
MLA (9th ed.) CitationAnjan Debnath, et al. CYP51 Is an Essential Drug Target for the Treatment of Primary Amoebic Meningoencephalitis (PAM). Public Library of Science (PLoS), 2017.
Warning: These citations may not always be 100% accurate.